Discover how leveraging MIDD can improve your early clinical development activities.

Join us to explore how harnessing the power of MIDD and its use of pharmacological, biological, medical and statistical principles and data can help you:

  • Accelerate and streamline clinical programs
  • Enable efficient trial and clinical development design and execution
  • Maximize probability of technical success
  • Obtain an approved product for patients and prescribers
Access the on-demand

Meet the Speaker

Alex MacDonald

VP of Model-informed Drug Development at Allucent

Register now to explore the concept of MIDD and its key methodologies. Understand how it can be used to improve early clinical trials, program progression, and decision-making.

Access the on-demand for forward-looking insights! 

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio

By completing this form you agree Pharma Intelligence and Allucent may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Pharma Intelligence and Allucent.